William He

William William is currently the Director of Portfolio and Program Management at Zai Lab, where they oversee program and portfolio management in the R&D stage. With over seven years of clinical trial experience, William has effectively managed Phase III registrational studies, primarily in oncology and CNS studies. Prior to their current role, William held positions including Associate Director, PPM at Zai Lab, Project Manager II at 上海药明康德新药开发有限公司, and various roles at GlaxoSmithKline, demonstrating strong skills in project management and clinical research. William is proficient in ICH-GCP and local regulatory standards, emphasizing excellence in execution and communication.